Interestingly, in NAFLD, a paradox emerges: despite elevated plasma glucagon levels, hepatic lipid oxidation is blunted due to hepatic glucagon resistance (49). This evidence concerns the gene GCG and metabolic dysfunction-associated steatotic liver disease.